Connor, Clark & Lunn Investment Management (CC&L)’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
SCM
Connor, Clark & Lunn Investment Management (CC&L)'s HALO Position: Q2 2025 in Review
Connor, Clark & Lunn Investment Management (CC&L) sold out of Halozyme (HALO) in Q2 2025, closing a stake of 42,133 shares — an estimated $2.69M sold.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in HALO in Q3 2013 and held it in 14 quarters. The position peaked at $6.61M in Q3 2023. 551 funds tracked by Wall St. Rank hold HALO as of Q2 2025.
- Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Halozyme position as of Q2 2025 after selling out during the quarter.
- Connor, Clark & Lunn Investment Management (CC&L) sold 42,133 Halozyme shares in Q2 2025, an estimated $2.69M.
- Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Halozyme in Q3 2013 and held it in 14 quarters.
- Connor, Clark & Lunn Investment Management (CC&L)'s Halozyme position peaked at $6.61M in Q3 2023.
- 551 funds tracked by Wall St. Rank held Halozyme as of Q2 2025.
Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2025, filed 7 Aug 2025.